Skip to content

Application of the new auscultation sphygmomanometer accutension xyz-111 in the screening of atrial fibrillation and the measurement of blood pressure in patients with atrial fibrillation

Application of the new auscultation sphygmomanometer accutension xyz-111 in the screening of atrial fibrillation and the measurement of blood pressure in patients with atrial fibrillation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000030344
Enrollment
Unknown
Registered
2020-02-29
Start date
2020-06-01
Completion date
Unknown
Last updated
2020-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension and atrial fibrillation

Interventions

Gold Standard:The gold standard for blood pressure is the pressure of a mercury manometer
ECG diagnosis is the gold standard for AF diagnosis.
Index test:Accutension XYZ-111

Sponsors

Shanghai First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Older than 18 years, regardless of gender; 2. Be able to communicate in language smoothly; 3. The patient agrees to participate in the trial and sign the informed consent; 4. The patient is in a stable period clinically.

Exclusion criteria

Exclusion criteria: 1. Suffering from acute pain or in a period of clinical instability; 2. Those whose arms are not healed or whose upper arms are missing; 3. Patients with bilateral upper extremity arterial occlusive disease; 4. Disease researchers who are not considered suitable to participate in this clinical trial by researchers.

Design outcomes

Primary

MeasureTime frame
blood pressure value;

Secondary

MeasureTime frame
occurence of AF;

Countries

China

Contacts

Public ContactZhi Zhang

Shanghai First People's Hospital

16683890@qq.com+86 13621759762

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026